Prognostic value of delta-like protein 3 combined with thyroid transcription factor-1 in small-cell lung cancer

Rovalpituzumab tesirine is a promising delta-like protein 3 (DLL3)-targeted antibody-drug conjugate for the treatment of small-cell lung cancer (SCLC). Thyroid transcription factor-1 (TTF-1) and DLL3 protein are associated with SCLC, and may be used to identify patients, who respond to the DLL3-targ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Li-Xu, Liu, Yan-Hui, Li, Zhi, Luo, Dong-Lan, Li, Yu-Fa, Yan, Jing-Hai, Zhang, Jia-Tao, Liu, Chao, Liu, Xun-Hua, He, Jiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676644/
https://www.ncbi.nlm.nih.gov/pubmed/31452726
http://dx.doi.org/10.3892/ol.2019.10538

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676644/
https://www.ncbi.nlm.nih.gov/pubmed/31452726
http://dx.doi.org/10.3892/ol.2019.10538

Ejemplares similares